BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34213087)

  • 1. Relationship between intelligence quotient measures and computerized neurocognitive performance in 22q11.2 deletion syndrome.
    Gur RC; Moore TM; Weinberger R; Mekori-Domachevsky E; Gross R; Emanuel BS; Zackai EH; Moss E; Gallagher RS; McGinn DE; Crowley TB; McDonald-McGinn D; Gothelf D; Gur RE
    Brain Behav; 2021 Aug; 11(8):e2221. PubMed ID: 34213087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurocognitive profile in psychotic versus nonpsychotic individuals with 22q11.2 deletion syndrome.
    Weinberger R; Yi J; Calkins M; Guri Y; McDonald-McGinn DM; Emanuel BS; Zackai EH; Ruparel K; Carmel M; Michaelovsky E; Weizman A; Gur RC; Gur RE; Gothelf D
    Eur Neuropsychopharmacol; 2016 Oct; 26(10):1610-8. PubMed ID: 27524298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the potential association among sleep disturbances, cognitive impairments, and immune activation in 22q11.2 deletion syndrome.
    Yirmiya ET; Mekori-Domachevsky E; Weinberger R; Taler M; Carmel M; Gothelf D
    Am J Med Genet A; 2020 Mar; 182(3):461-468. PubMed ID: 31837200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of COMT and PRODH gene variants with intelligence quotient (IQ) and executive functions in 22q11.2DS subjects.
    Carmel M; Zarchi O; Michaelovsky E; Frisch A; Patya M; Green T; Gothelf D; Weizman A
    J Psychiatr Res; 2014 Sep; 56():28-35. PubMed ID: 24853458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative subthreshold psychotic symptoms distinguish 22q11.2 deletion syndrome from other neurodevelopmental disorders: A two-site study.
    Mekori-Domachevsky E; Guri Y; Yi J; Weisman O; Calkins ME; Tang SX; Gross R; McDonald-McGinn DM; Emanuel BS; Zackai EH; Zalsman G; Weizman A; Gur RC; Gur RE; Gothelf D
    Schizophr Res; 2017 Oct; 188():42-49. PubMed ID: 28041919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Education and employment trajectories from childhood to adulthood in individuals with 22q11.2 deletion syndrome.
    Mosheva M; Pouillard V; Fishman Y; Dubourg L; Sofrin-Frumer D; Serur Y; Weizman A; Eliez S; Gothelf D; Schneider M
    Eur Child Adolesc Psychiatry; 2019 Jan; 28(1):31-42. PubMed ID: 29934817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remote assessment of the Penn computerised neurocognitive battery in individuals with 22q11.2 deletion syndrome.
    White LK; Hillman N; Ruparel K; Moore TM; Gallagher RS; McClellan EJ; Roalf DR; Scott JC; Calkins ME; McGinn DE; Giunta V; Tran O; Crowley TB; Zackai EH; Emanuel BS; McDonald-McGinn DM; Gur RE; Gur RC
    J Intellect Disabil Res; 2024 Apr; 68(4):369-376. PubMed ID: 38229473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An examination of the relationship of anxiety and intelligence to adaptive functioning in children with chromosome 22q11.2 deletion syndrome.
    Angkustsiri K; Leckliter I; Tartaglia N; Beaton EA; Enriquez J; Simon TJ
    J Dev Behav Pediatr; 2012; 33(9):713-20. PubMed ID: 23117596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The motor profile of primary school-age children with a 22q11.2 deletion syndrome (22q11.2DS) and an age- and IQ-matched control group.
    Van Aken K; Caeyenberghs K; Smits-Engelsman B; Swillen A
    Child Neuropsychol; 2009 Nov; 15(6):532-42. PubMed ID: 19280375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Computerized Neurocognitive Battery: Validation, aging effects, and heritability across cognitive domains.
    Swagerman SC; de Geus EJC; Kan KJ; van Bergen E; Nieuwboer HA; Koenis MMG; Hulshoff Pol HE; Gur RE; Gur RC; Boomsma DI
    Neuropsychology; 2016 Jan; 30(1):53-64. PubMed ID: 26710096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neurocognitive and psychiatric management of the 22q11.2 deletion syndrome].
    Demily C; Rossi M; Schneider M; Edery P; Leleu A; d'Amato T; Franck N; Eliez S
    Encephale; 2015 Jun; 41(3):266-73. PubMed ID: 25523123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A binational study assessing risk and resilience factors in 22q11.2 deletion syndrome.
    Gur RE; White LK; Shani S; Barzilay R; Moore TM; Emanuel BS; Zackai EH; McDonald-McGinn DM; Matalon N; Weinberger R; Gur RC; Gothelf D
    J Psychiatr Res; 2021 Jun; 138():319-325. PubMed ID: 33894539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Untargeted metabolic analysis in dried blood spots reveals metabolic signature in 22q11.2 deletion syndrome.
    Korteling D; Boks MP; Fiksinski AM; van Hoek IN; Vorstman JAS; Verhoeven-Duif NM; Jans JJM; Zinkstok JR
    Transl Psychiatry; 2022 Mar; 12(1):97. PubMed ID: 35264571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct neurocognitive profiles and clinical phenotypes associated with copy number variation at the 22q11.2 locus.
    O'Hora KP; Kushan-Wells L; Schleifer CH; Cruz S; Hoftman GD; Jalbrzikowski M; Gur RE; Gur RC; Bearden CE
    Autism Res; 2023 Dec; 16(12):2247-2262. PubMed ID: 37997544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variance of IQ is partially dependent on deletion type among 1,427 22q11.2 deletion syndrome subjects.
    Zhao Y; Guo T; Fiksinski A; Breetvelt E; McDonald-McGinn DM; Crowley TB; Diacou A; Schneider M; Eliez S; Swillen A; Breckpot J; Vermeesch J; Chow EWC; Gothelf D; Duijff S; Evers R; van Amelsvoort TA; van den Bree M; Owen M; Niarchou M; Bearden CE; Ornstein C; Pontillo M; Buzzanca A; Vicari S; Armando M; Murphy KC; Murphy C; Garcia-Minaur S; Philip N; Campbell L; Morey-Cañellas J; Raventos J; Rosell J; Heine-Suner D; Shprintzen RJ; Gur RE; Zackai E; Emanuel BS; Wang T; Kates WR; Bassett AS; Vorstman JAS; Morrow BE;
    Am J Med Genet A; 2018 Oct; 176(10):2172-2181. PubMed ID: 30289625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurocognitive Profiles of 22q11.2 and 16p11.2 Deletions and Duplications.
    Gur R; Bearden C; Jacquemont S; Jizi K; Amelsvoort van T; van den Bree M; Vorstman J; Sebat J; Ruparel K; Gallagher R; Swillen A; McClellan E; White L; Crowley T; Giunta V; Kushan L; O'Hora K; Verbesselt J; Vandensande A; Vingerhoets C; van Haelst M; Hall J; Harwood J; Chawner S; Patel N; Palad K; Hong O; Guevara J; Martin CO; Bélanger AM; Scherer S; Bassett A; McDonald-McGinn D; Gur R
    Res Sq; 2023 Dec; ():. PubMed ID: 38234766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive development in children with 22q11.2 deletion syndrome.
    Duijff SN; Klaassen PW; de Veye HF; Beemer FA; Sinnema G; Vorstman JA
    Br J Psychiatry; 2012 Jun; 200(6):462-8. PubMed ID: 22661678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychological Profile of 25 Brazilian Patients with 22q11.2 Deletion Syndrome: Effects of Clinical and Socioeconomic Variables.
    Pimenta LSE; Mello CB; Benedetto LMD; Soares DCQ; Kulikowski LD; Dantas AG; Melaragno MI; Kim CA
    Genes (Basel); 2024 May; 15(5):. PubMed ID: 38790224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subthreshold social cognitive deficits may be a key to distinguish 22q11.2DS from schizophrenia.
    Peyroux E; Rigard C; Saucourt G; Poisson A; Plasse J; Franck N; Demily C
    Early Interv Psychiatry; 2019 Apr; 13(2):304-307. PubMed ID: 29575660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance on a computerized neurocognitive battery in 22q11.2 deletion syndrome: A comparison between US and Israeli cohorts.
    Yi JJ; Weinberger R; Moore TM; Calkins ME; Guri Y; McDonald-McGinn DM; Zackai EH; Emanuel BS; Gur RE; Gothelf D; Gur RC
    Brain Cogn; 2016 Jul; 106():33-41. PubMed ID: 27200494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.